Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
NCT00721656 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2009-03-18
Summary
To evaluate the efficacy and safety of KLS-0611 compared to placebo in patients with dry eye syndromes.
Conditions
- Dry Eye Syndromes
Interventions
- DRUG
- DRUG
-
KLS-0611
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Yasuhiro Omori · Kissei Pharmaceutical Co., Ltd.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Japan
More Related Trials
-
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
NCT02188160 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001
NCT05017870 ·Status: COMPLETED ·Phase: PHASE1
-
[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome
NCT05017844 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
NCT01670357 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Study for Safety and Tolerability of HL036
NCT02717208 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients
NCT06337981 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients
NCT06291194 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
NCT02813265 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
NCT01768312 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
NCT05759208 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
NCT04884217 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers
NCT01162954 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
NCT04633213 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
NCT00037661 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503189 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of USL for Dry Eye Disease
NCT06016010 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.
NCT03723811 ·Status: COMPLETED ·Phase: PHASE2
-
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
NCT02205840 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
NCT02819284 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.
NCT03723798 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
Study of OT202 in Treating Moderate to Severe Dry Eye
NCT06435182 ·Status: COMPLETED ·Phase: PHASE2